| 摘要 |
PROBLEM TO BE SOLVED: To provide a new cell growth inhibitor containing an anti-glypican 3 antibody as an active ingredient. SOLUTION: The therapeutic agent contains the anti-glypican 3 antibody as an active ingredient. The preparation for therapy contains the anti-glypican 3 antibody, and a pharmaceutically acceptable carrier or additive. Preferably the preparation for the therapy is a cell proliferation inhibitor. Preferably the anti-glypican 3 antibody is a monoclonal antibody. Further preferably, the anti-glypican 3 antibody has cytotoxic activities. COPYRIGHT: (C)2007,JPO&INPIT
|
